“Beyond Weight Loss: Practical Considerations for use of Glucagon like Peptide-1 (GLP-1) and Incretin Therapy in Inflammatory Skin Disease” (2026) Canadian Dermatology Today, 7(3), pp. 11–16. doi:10.58931/cdt.2026.73168.